Clinical Trials Browser

Phase 4 × OTHER × Venous Thromboembolism × Clear all

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07303816 2025-12-26

STAT-CAT

Phase 4 Not yet recruiting

4,000 enrolled

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4 Enrolling by invitation

2,868 enrolled

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

330 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

21 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Phase 4 Completed

19 enrolled 10 charts

Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

NCT04479579 2022-04-22

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Phase 4 Completed

53 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism, Medication Adherence

NCT03988231 2021-10-08

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Phase 4 Withdrawn

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03006562 2020-08-05

PREVENTER

Phase 4 Terminated

501 enrolled 13 charts

Classical hematologyGenitourinary

Prostatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Phase 4 Completed

87 enrolled 9 charts

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Clinical Trials

AmiCARE

STAT-CAT

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

STREAM-Line

ROSIE

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

PREVENTER

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients